Two Sigma Advisers
SILK

Two Sigma Advisers’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Two Sigma Advisers’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-732,900
Closed -$19.8M – 2581
2024
Q2 		$19.8M Sell
732,900
-23,100
-3% -$480K 0.04% 337
2024
Q1 		$13.8M Buy
756,000
+98,600
+15% +$1.56M 0.03% 430
2023
Q4 		$8.07M Buy
657,400
+232,900
+55% +$2.18M 0.02% 617
2023
Q3 		$6.36M Buy
424,500
+142,800
+51% +$2.97M 0.02% 630
2023
Q2 		$9.15M Buy
281,700
+140,100
+99% +$5.12M 0.02% 520
2023
Q1 		$5.54M Buy
141,600
+129,700
+1,090% +$6.34M 0.01% 767
2022
Q4 		$629K Buy
+11,900
New +$580K ﹤0.01% 1782
2021
Q3 		– Sell
-52,700
Closed -$2.52M – 2732
2021
Q2 		$2.52M Sell
52,700
-2,700
-5% -$138K 0.01% 1184
2021
Q1 		$2.81M Buy
55,400
+48,300
+680% +$2.68M 0.01% 1107
2020
Q4 		$447K Buy
+7,100
New +$440K ﹤0.01% 1909

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Advisers's SILK Position: Q3 2024 in Review

Two Sigma Advisers sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 732,900 shares — an estimated $19.8M sold.

Two Sigma Advisers first reported a position in SILK in Q4 2020 and held it in 10 quarters. The position peaked at $19.8M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Two Sigma Advisers reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 732,900 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $19.8M.
  • Two Sigma Advisers first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 10 quarters.
  • Two Sigma Advisers's Silk Road Medical, Inc. Common Stock position peaked at $19.8M in Q2 2024.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Two Sigma Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.